-
Bioengineered Protein Drugs Strategic Research Report 2023-2030: Advances in Genetic Engineering Propel Growth, Adoption of CRISPR and Gene-Editing Tools Accelerates Developments - ResearchAndMarkets.com
11 Sep 2024 13:15 GMT
… to be tailored to individual genetic profiles.
Additionally, favorable regulatory policies … TRENDS & DRIVERS
Advances in Genetic Engineering Propel Growth in Bioengineered … Ltd.
Amgen, Inc.
Bayer AG
Biocon Ltd.
Dr. Reddy's …
-
U.S. P2Y12 Inhibitors Market Set to Witness Significant Growth by 2024-2031: Panacea Biotec, Lupin, Cipla, Biocon
11 Sep 2024 10:44 GMT
… : Advancements in personalized medicine, particularly genetic testing for CYP2C19 variants, are …
◘ CHIESI USA Inc.
◘ Lupin
◘ Cipla
◘ Biocon
Deep-dive Analysis:
The Report …
-
Biocon Foundation and IISc organise OCTF conference on AI in oral cancer
31 Jul 2024 04:38 GMT
… Dr Anupama Shetty, Mission Director, Biocon Foundation, graced the conference and … .
Dr Anupama Shetty, Mission Director, Biocon Foundation, said, “The publication of … outcomes, and personalised medicine through genetic analysis. Thus having the potential …
-
Biocon Biologics, Sandoz ink pact for distribution of immune disorder injection Adalimumab in Japan
23 Dec 2023 08:15 GMT
… of Humira (generic name: adalimumab (genetical recombination)) and is indicated for … portfolio," the release stated.
Biocon Biologics recently announced the successful … immunology, and ophthalmology.
Read also: Biocon arm completes integration of Viatris …
-
Biocon Biologics Partners with Sandoz for the Distribution of 'Adalimumab BS Subcutaneous Injection [FKB]' in Japan
22 Dec 2023 16:00 GMT
… global marketing license agreement with Biocon Biologics Ltd affiliate.
Adalimumab … of Humira® (generic name: adalimumab (genetical recombination)) and is indicated for … s immunology and biosimilar portfolio.
Biocon Biologics recently announced the successful …
-
Biocon Biologics inks agreement with Sandoz to promote, sell, distribute FKB in Japan
22 Dec 2023 14:17 GMT
Adalimumab BS for subcutaneous injection [FKB] is a biosimilar of Humira (generic name: adalimumab (genetical recombination)) and is indicated for immune-related diseases such as rheumatoid arthritis, psoriasis vulgaris, ankylosing spondylitis, Crohn's …
-
All about India’s 1st ‘living drug’ that uses patient’s own genetically engineered cells to fight cancer
16 Oct 2023 15:05 GMT
… a patient’s own genetically engineered cell to target … start-up backed by Biocon founder Kiran Mazumdar Shaw … called apheresis and are genetically engineered to recognise the … the clinical trials.
“Following genetic engineering, during which scientists …
-
Biotechnology Market | Pioneering Innovations in Healthcare, Agriculture, and Sustainability for a Transformative Future
11 Dec 2024 16:23 GMT
… growth, driven by advancements in genetic engineering, biopharmaceuticals, and agricultural … precision to gene editing, addressing genetic mutations with transformative potential.
… companies like WuXi AppTec and Biocon are spearheading the change. …
-
Can Genetic Rescue Save This Critically Endangered Songbird?
16 Aug 2023 22:47 GMT
… doi:10.1016/j.biocon.2023.110203
The adaptive differences … -cockaded Woodpecker.”
Increasing the genetic diversity of declining populations is … doi:10.1016/j.biocon.2023.110203
SHA-256: 9ab94921e06b203a216cb219d873f92ea4083642075e2e0be632939cd42949aa …
-
Genetic rescue program to save the iconic Helmeted Honeyeater outweighs any risks, study finds
09 Aug 2023 23:11 GMT
… another subspecies to improve genetic health and fitness, … birds. The addition of genetic variation from another population … in Biological Conservation.
Captive genetic rescue efforts are underway … #47;j.biocon.2023.110203
Citation:
Genetic rescue program to …
About
© 1995-2025